Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1997 | 12-1996 | 09-1996 | 06-1996 | 03-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 156,970 | N/A | N/A | N/A |
| Marketable Securities | N/A | 324,950 | N/A | N/A | N/A |
| Receivables | N/A | 974,010 | N/A | N/A | N/A |
| Inventories | N/A | 431,150 | N/A | N/A | N/A |
| Other current assets | 0 | 10 | 0 | 0 | 0 |
| TOTAL | $N/A | $1,887,090 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 45,610 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 37,860 | 0 | 0 | 0 |
| TOTAL | $N/A | $83,470 | $N/A | $N/A | $N/A |
| Total Assets | $N/A | $3,826,850 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 134,250 | 0 | 0 | 0 |
| Other current liabilities | N/A | 443,890 | N/A | N/A | N/A |
| TOTAL | $N/A | $842,850 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 162,470 | N/A | N/A | N/A |
| aiOther Non-Current Liabilities | 0 | 70,730 | 0 | 0 | 0 |
| TOTAL | $N/A | $233,200 | $N/A | $N/A | $N/A |
| Total Liabilities | $N/A | $1,076,070 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | N/A | 129,080 | N/A | N/A | N/A |
| Retained earnings | N/A | 2,165,740 | N/A | N/A | N/A |
| Other shareholders' equity | 0 | 18,950 | 0 | 0 | 0 |
| TOTAL | $N/A | $2,750,770 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $0 | $3,826,840 | $0 | $0 | $0 |